Wednesday, June 10, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “postoperative” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 75
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 75 pipeline programs matching "postoperative" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

75 results for “postoperative” Back to intelligence hub

Search results

Page 1 of 4
  1. Bupivacaine

    United Therapeutics Europe Ltd

    Postoperative Pain

    phase 3 small molecule active

    1 trial
  2. Bupivacaine HCl

    Pacira Ireland Limited

    Postoperative Pain

    phase 3 small molecule completed

    3 trials
  3. Exparel

    Pacira Ireland Limited

    Postoperative Pain Management

    phase 3 small molecule completed

    3 trials
  4. Intravenous Ibuprofen

    CUMBERLAND PHARMACEUTICALS INC

    Postoperative Pain

    phase 3 small molecule active

    1 trial
  5. Normal Saline

    The First People's Hospital of Lianyungang

    Postoperative Sleep Disturbance

    phase 3 small molecule active

    1 trial
  6. Oral triiodothyronine

    Cardiff Oncology

    Postoperative; Dysfunction Following Cardiac Surgery

    phase 3 small molecule completed

    1 trial
  7. PF614 capsule

    Ensysce Biosciences

    Postoperative Pain, Acute

    phase 3 small molecule active

    1 trial
  8. Placebo

    Pacira Ireland Limited

    Postoperative Pain

    phase 3 small molecule completed

    1 trial
  9. Tetrahydrocannabinol

    Jazz Pharmaceuticals Ireland Limited

    Pain, Postoperative

    phase 3 small molecule active

    1 trial
  10. Tetronine

    Cardiff Oncology

    Postoperative; Dysfunction Following Cardiac Surgery

    phase 3 small molecule completed

    1 trial
  11. UVEDOSE 100 000 UI, solution buvable en ampoule

    Novo Nordisk A/S

    Thyroidectomy is a common operation. Transient postoperative hypocalcemia is the main complication, resulting in clinical discomfort for patients, longer hospital stays and increased perioperative cost. Cholecalciferol is used to supplement vitamin D deficiency. We suppose that systematic pre-operative supplementation with cholecalciferol would allow a faster and more appropriate response to post-operative hypocalcemia

    phase 3 small molecule active

    1 trial
  12. bupivacaine liposome injectable suspension

    Pacira Ireland Limited

    Pain, Postoperative

    phase 3 small molecule active

    1 trial
  13. postoperative antimicrobial prophylaxis

    Sun Yat-sen University

    Hepatocellular Carcinoma

    phase 3 small molecule on hold

    1 trial
  14. ACP-044 Dose A

    Acadia Pharmaceuticals B.V.

    Acute Postoperative Pain

    phase 2 small molecule completed

    1 trial
  15. BOTOX 100 Allergan Units Powder for Solution for Injection

    Disc Medicine

    postoperative pancreatic fistulas

    phase 2 small molecule active

    1 trial
  16. GW679769

    GlaxoSmithKline

    Postoperative Nausea and Vomiting

    phase 2 small molecule completed

    1 trial
  17. HTX-011A

    Heron Therapeutics

    Postoperative Pain

    phase 2 small molecule completed

    1 trial
  18. HTX-011B

    Heron Therapeutics

    Postoperative Pain

    phase 2 small molecule completed

    1 trial
  19. Lidocaine Hydrochloride, Injectable

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postoperative Chronic Pain

    phase 2 small molecule active

    1 trial
  20. Low Dose SKY0402

    Pacira Ireland Limited

    Postoperative Pain

    phase 2 small molecule terminated

    1 trial
  21. Ondansetron (ODFS)

    Aquestive Therapeutics

    Nausea and Vomiting, Postoperative

    phase 2 small molecule completed

    1 trial
  22. Postoperative adjuvant lenvatinib

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma (HCC)

    phase 2 small molecule active

    1 trial
  23. SKY0402

    Pacira Ireland Limited

    Postoperative Pain

    phase 2 small molecule completed

    3 trials
  24. SKY0402 + bupivacaine HCl

    Pacira Ireland Limited

    Postoperative Pain

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.